CFMTI

CAS No. 864864-17-5

CFMTI( CFMTI )

Catalog No. M17627 CAS No. 864864-17-5

CFMTI is a potent and selective metabotropic glutamate receptor (mGluR) 1 allosteric antagonist (IC50: 2.6 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 136 In Stock
2MG 75 In Stock
5MG 123 In Stock
10MG 180 In Stock
25MG 321 In Stock
50MG 445 In Stock
100MG 621 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CFMTI
  • Note
    Research use only, not for human use.
  • Brief Description
    CFMTI is a potent and selective metabotropic glutamate receptor (mGluR) 1 allosteric antagonist (IC50: 2.6 nM).
  • Description
    CFMTI is a potent and selective metabotropic glutamate receptor (mGluR) 1 allosteric antagonist (IC50: 2.6 nM). The selectivity of CFMTI to mGluR1 is higher 2000-fold than mGluR5.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CFMTI
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Beta Amyloid
  • Recptor
    mGluR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    864864-17-5
  • Formula Weight
    349.37
  • Molecular Formula
    C19H16FN5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 6.2 mg/mL. 17.75 mM;
  • SMILES
    c1(c(nccc1)F)n1nnc(c1C)c1ccc2c(c1)CN(C2=O)C1CC1
  • Chemical Name
    2-Cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Satow A et al. 2009 Jul;330(1):179-90.
molnova catalog
related products
  • NSC 6038

    NSC 6038

  • PPI-1019

    PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).

  • Fenlean

    Fenlean (FLZ) is a tyrosine kinase Src inhibitor, a synthetic cyclic derivative of squamous amide from Annona glabra, with cytoprotective activity, which protects tyrosine hydroxylase function in a chronic MPTP/prostaglandin-type mouse model of Parkinson's disease.